In our study, cTfh cells from RA patients exhibit higher levels of glycolytic molecules GLUT1 and HK2, which may be linked to the CXCL13-CXCR5 axis-mediated mTOR activation. The gene discussed is CXCL13; the disease is rheumatoid arthritis.